seed
Stage
2
Investors
About
Maracells develops cell-based assays that predict individual patient responses to cancer treatments, facilitating personalized oncology therapy.
Explore Maracells's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.